Celldex Therapeutics
CLDX
$37.00
Share price
1.93%
Change (1 day)
17.68%
Change (1 year)
Categories
Number of shares outstanding for Celldex Therapeutics (CLDX)
Number of shares outstanding as of April 2024 : 47,261,000
According to Celldex Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 47,261,000. At the end of 2023 the company had 47,261,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Celldex Therapeutics from 2019 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 47.26 M | 0.27% |
| 2022 | 47.13 M | 0.94% |
| 2021 | 46.69 M | 17.98% |
| 2020 | 39.57 M | 140.71% |
| 2019 | 16.44 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 11,848.54% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 1,032.01% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,028,000,000 | 4,191.06% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | 750,800 | -98.41% | 🇺🇸 USA |
 Seagen
SGEN | 188,135,000 | 298.08% | 🇺🇸 USA |
 Agenus
AGEN | 378,152,000 | 700.14% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 51,800,000 | 9.60% | 🇺🇸 USA |